We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.67B
AUM Growth
+$159M
Cap. Flow
+$11.7M
Cap. Flow %
0.7%
Top 10 Hldgs %
44.6%
Holding
84
New
7
Increased
30
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$24.9M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$17.7M
3
ATEC icon
Alphatec Holdings
ATEC
+$15.5M
4
INSM icon
Insmed
INSM
+$12.9M
5
RLAY icon
Relay Therapeutics
RLAY
+$12.9M

Top Sells

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$31.4M
2
CDNA icon
CareDx
CDNA
+$25.2M
3
BTAI icon
BioXcel Therapeutics
BTAI
+$15.5M
4
MRVI icon
Maravai LifeSciences
MRVI
+$11.2M
5
HCAT icon
Health Catalyst
HCAT
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 83.7%
2 Communication Services 4.44%
3 Energy 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
76
Pfizer
PFE
$143B
$332K 0.02%
8,469
– –
UHS icon
77
Universal Health Services
UHS
$10.2B
$300K 0.02%
2,050
– –
EBS icon
78
Emergent Biosolutions
EBS
$373M
$270K 0.02%
4,294
– –
MCK icon
79
McKesson
MCK
$100B
$257K 0.02%
1,346
– –
BTAI icon
80
BioXcel Therapeutics
BTAI
$24.9M
– –
-22,402
Closed -$15.5M
JAZZ icon
81
Jazz Pharmaceuticals
JAZZ
$15.9B
– –
-53,484
Closed -$8.79M
MASS icon
82
908 Devices
MASS
$329M
– –
-20,700
Closed -$1M
QTRX icon
83
Quanterix
QTRX
$164M
– –
-27,100
Closed -$1.58M
ZYME icon
84
Zymeworks
ZYME
$1.61B
– –
-117,848
Closed -$3.72M
1 2 3
4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, First Light Asset Management held 84 positions worth $1.67B, up 11% from $1.51B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

First Light Asset Management's Q2 2021 filing shows 7 new, 30 increased, 18 reduced and 5 closed positions. Its largest new stake was Relay Therapeutics: 390,555 shares worth $14.3M. The largest sale was Prothena Corp, an estimated $31.4M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 84% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q2 2021 buy was Relay Therapeutics: 390,555 shares worth $14.3M.
  • First Light Asset Management added most to Turning Point Therapeutics, Inc. Common Stock in Q2 2021, an estimated $24.9M increase.
  • First Light Asset Management's biggest Q2 2021 reduction was Prothena Corp, cutting an estimated $31.4M.
  • First Light Asset Management fully exited BioXcel Therapeutics in Q2 2021, selling an estimated $15.5M.
  • First Light Asset Management's ten largest holdings make up 45% of its $1.67B portfolio in Q2 2021.
  • First Light Asset Management opened 7 new positions and closed 5 in Q2 2021.
  • First Light Asset Management's portfolio value rose 11% quarter-over-quarter to $1.67B.

Based on First Light Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.